Description

This action aims to support actions of innovation and sustainability that can empower the pharmaceutical and health products taking into account both the context of the output of the crisis resulting from the COVID 19 such as the need for a recovery in key ecological, on the basis of climate neutrality and environmental protection, all through the implementation of industrial research, technological development, innovation in processes and organization, as well as investments aimed at sustainability by improving the efficiency and environmental protection beyond the rules of the union.

Access Mode

Digital Certificate

Management Centre

General Secretariat of Industry and Small and Medium Enterprises - E04934403

Directorate General

Overall Direccion industry and small and medium enterprises

Management unit

S. of management and Implementation of programmes

Topic

Subsidies, Grants and Awards

Additional information

Management Information System Procedures

S.I.A. Code: 2860222

Strategic projects for the industrial transition of the pharmaceutical sector and the medical device sector